Key Dates

Related Announcements

NOT-OD-20-121 - Notice of Special Interest (NOSI): Limited Competition for Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations

NOT-OD-20-120 - Notice of Special Interest (NOSI): Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations

NOT-OD-20-119 - Notice of Special Interest (NOSI): Emergency Competitive Revisions for Social, Ethical, and Behavioral Implications (SEBI) Research on COVID-19 Testing among Underserved and/or Vulnerable Populations

NOT-OD-21-103 - Notice of Special Interest (NOSI): Emergency Competitive Revisions for Community-engaged COVID-19 Testing Interventions among Underserved and Vulnerable Populations RADx-UP Phase II (Emergency Supplement - Clinical Trial Optional)

NOT-OD-21-101 - Notice of Special Interest (NOSI): Administrative Supplements for Rapid Acceleration of Diagnostics-Underserved Populations (RADx-UP) Phase I Projects to Address Vaccine Hesitancy and Uptake

Issued by

NATIONAL INSTITUTES OF HEALTH (NIH)

Purpose

The purpose of this notice is to update the terms and conditions of award for recipients of competitive revision awards under the RADx Underserved Populations (RADx-UP) initiative. This includes all awards issued in response to the following Notices of Special Interest:

• NOT-OD-20-121 Notice of Special Interest (NOSI): Limited Competition for Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations
• NOT-OD-20-120 Notice of Special Interest (NOSI): Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations
• NOT-OD-20-119 Notice of Special Interest (NOSI): Emergency Competitive Revisions for Social, Ethical, and Behavioral Implications (SEBI) Research on COVID-19 Testing among Underserved and/or Vulnerable Populations

This guide notice does not apply to awards issued outside of these NOSIs.

Multiple Program Director/Principal Investigator Requirements

Recipients are reminded that for competitive revisions to parent awards that include multiple PD/PIs, the supplement must align with the PD/PIs on the parent award. Recipients may add members to the leadership team outside of the named PD/PIs, to provide expertise needed for the supplemental activities; the contact PD/PI and Multi-PD/PIs may not differ from the parent award. Any changes to the PD/PIs must be submitted as a prior approval request, along with an updated leadership plan for the award.

Interim Reports

In addition to the annual RPPR, recipients of awards issued in response to NOT-OD-20-119, NOT-OD-20-120 and NOT-OD-20-121 are required to submit an interim progress report every six months outlining key milestones that have been met.

Below are additional instructions on what NIH is requiring recipients of these NOSIs to submit as a part of their interim report.

• The Additional Materials tool (AM) in eRA will be available for recipients beginning in March 2021. Recipients must upload the interim report using AM. The Authorized Organization Official is required to submit interim reports to the Grants Management Official named on the Notice of Award using AM.

• The interim progress report must outline for each competitive revision supplement the following:
  • For each specific aim, a brief summary of major activities, significant results, and key outcomes or other achievements.
  • Out of the amount of funding that have been obligated, how much remains unobligated, and how much is an unliquidated obligation?
  • Outline whether the recipient is on track to meet the 75% spending milestone, if not, provide a justification.

• Please use the following due dates for interim reports:
  • For awards issued in September 2020: March 31, 2021
  • For awards issued in November 2020: May 31, 2021

Annual Reports

Recipients will continue to report information on the competitive revision supplements in the annual RPPR, Section G.1, as directed by the current term of award, and must include updates to the information provided in the interim report (as outlined in the above bullets).

For supplements where the parent award is in an extension, and no further RPPRs are due, recipients must submit their annual reports, including budget information for the next year, using AM.

Carryover

NIH expects recipients of awards issued in response to NOT-OD-20-121 and NOT-OD-20-120 to complete 75% of their milestones along with the accompanying budget within the first 12 months of the project. For these awards, in alignment with standard NIH terms and conditions, recipients maintain authority for automatic carryover of unobligated balances. NIH staff will regularly monitor drawdowns in the Payment Management System to determine whether there are large unobligated balances. Consistent with existing NIH discretion, awards may be offset where the recipient has not met performance and expenditure milestones.

Inquiries

Please direct grants policy inquiries to:

NIH Office of Policy for Extramural Research Administration

Division of Grants Policy

[email protected]

For questions regarding a specific grant award please contact the Grants Management Specialist identified in the Notice of Award.